CG Oncology, Inc.
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -114.69% | -119.16% | -103.45% | -92.07% | -101.19% |
| Total Depreciation and Amortization | 1,880.95% | 2,128.57% | 500.00% | -100.00% | 425.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 593.41% | 2,120.87% | 783.50% | 1,031.34% | 153.70% |
| Change in Net Operating Assets | -184.45% | 188.29% | 105.59% | 89.40% | 932.47% |
| Cash from Operations | -144.32% | -73.44% | -12.55% | -41.09% | -69.60% |
| Capital Expenditure | -9,800.00% | 0.00% | -33.33% | -- | 133.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.95% | 103.92% | 39.25% | -28.45% | 159.52% |
| Cash from Investing | -52.99% | 103.88% | 39.25% | -29.80% | 159.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | 2,396.54% | -75.32% | -99.83% | 85,172.52% | 1,760.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -751.35% | 93.15% | 100.00% | -- |
| Cash from Financing | 2,409.00% | -840.00% | -99.89% | 7,814.57% | 127.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.21% | 48.68% | -411.55% | 10,745.59% | 461.30% |